AGBT meeting: Study workshop on complete genome sequencing for human disease

Complete Genomics Inc., a third-generation human genome sequencing company, today announced that it will be unveiling some of its highly anticipated customer results at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting to be held in Marco Island, Fla., Feb. 24-27, 2010.

“Complete Genome Sequencing for Human Disease Studies”

Chairman, President, and Chief Executive Officer Dr. Clifford Reid will conduct a workshop titled “Complete Genome Sequencing for Human Disease Studies,” which will examine Complete Genomics’ successful collaborations with customers, alongside speakers from current customers Genentech and the Institute for Systems Biology, who will present an overview of their work to date. This will take place on Saturday, Feb. 27, at 1 p.m. EST in the Islands Ballroom, Marco Island Marriott Resort & Golf Club.

Following the workshop, Chief Scientific Officer Dr. Rade Drmanac will discuss Complete Genomics’ disruptive technology platform and its road map of future innovations as part of a presentation titled “Technology and Infrastructure Development for Sequencing Thousands of High Quality, Complete Human Genomes for Large-Scale Disease Studies” at 2 p.m. EST in the Islands Ballroom.

Complete Genomics will also be hosting a hospitality suite for AGBT attendees on Feb. 25 and 26 in the Caxambas Room from 10 a.m. to 5 p.m. EST each day. Guests will have an opportunity to meet members of the Complete Genomics team and to learn more about the advantages of outsourcing large-scale human genome sequencing.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI identifies novel gene variants linked to Alzheimer’s risk